1-20 of 54
Mark Basik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B025: Primary and metastatic tumors from triple negative breast cancer possess distinct immunological profiles

Alexandra D. Goudreau, Alexandre Penoit, Jade Marie Lasiste, Olga Aleynikova, Khaled Katergi, Josiane Lafleur, Adriana Aguilar-Mahecha, Mark Basik
Journal: Cancer Research
Cancer Res (2024) 84 (22_Supplement): B025.
https://doi.org/10.1158/1538-7445.TUMBODY-B025
Published: 17 November 2024
View article titled, Abstract B025: Primary and metastatic tumors from triple negative breast cancer possess distinct immunological profiles
Journal Articles

Abstract PO2-14-04: Circulating tumor DNA after neoadjuvant chemotherapy is a better prognostic test than Residual Cancer Burden in patients with triple negative breast cancer and residual tumor

Mark Basik, Talia Roseshter, Anna Klemantovich, Luca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, Cathy Lan, Oluwadara Elebute, Sarah Jenna, Jean-Francois Boileau, Manuela Pelmus
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-14-04.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-14-04
Published: 02 May 2024
View article titled, Abstract PO2-14-04: Circulating tumor DNA after neoadjuvant chemotherapy is a better prognostic test than Residual Cancer Burden in patients with triple negative breast cancer and residual tumor
Journal Articles

Abstract PO2-08-07: Evaluating chemotherapy receipt and candidacy for PARP inhibitors in germline BRCA1/2 carriers with early and locally advanced breast cancer

Stephanie Wong, Carla Apostolova, Amina Ferroum, Basmah Alhassan, Ipshita Prakash, Mark Basik, Karyne Martel, Sarkis Meterissian, David Fleiszer, Nora Wong, Talia Malagon, William Foulkes, Jean-Francois Boileau
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-08-07.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-08-07
Published: 02 May 2024
View article titled, Abstract PO2-08-07: Evaluating chemotherapy receipt and candidacy for PARP inhibitors in germline BRCA1/2 carriers with early and locally advanced breast cancer
Journal Articles

Abstract PO4-15-01: A multi-center prospective cohort study to evaluate the presence of circulating tumor cells using the Epic Sciences platform among women with metastatic breast cancer

Katarzyna Jerzak, Pamela Goodwin, Marguerite Ennis, Christine Brezden-Masley, Nathaniel Bouganim, Mark Basik, Arushi Jain, Giuseppe Di Caro, Rick Wenstrup, Nadine Hartmann, Megan Slade, Ana Elisa Lohmann
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-15-01.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-15-01
Published: 02 May 2024
View article titled, Abstract PO4-15-01: A multi-center prospective cohort study to evaluate the presence of circulating tumor cells using the Epic Sciences platform among women with metastatic breast cancer
Journal Articles

Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

Qianyu Guo, Vivian Z. Li, Jessica N. Nichol, Fan Huang, William Yang, Samuel E.J. Preston, Zahra Talat, Hanne Lefrère, Henry Yu, Guihua Zhang, Mark Basik, Christophe Gonçalves, Yao Zhan, Dany Plourde, Jie Su, Jose Torres, Maud Marques, Sara Al Habyan, Krikor Bijian, Frédéric Amant, Michael Wichter, Fariba Behbod, Luke McCaffrey, Moulay Alaoui-Jamali, Nadia V. Giannakopoulos, Muriel Brackstone, Lynne-Marie Postovit, Sonia V. del Rincón, William H. Miller, Jr
Journal: Cancer Research
Cancer Res (2024) 84 (8): 1373.
https://doi.org/10.1158/0008-5472.CAN-24-0461
Published: 15 April 2024
View article titled, Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <em>In Situ</em>
Open the PDF for Correction: MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <em>In Situ</em> in another window
Journal Articles

Abstract P2-11-26: The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor

Talia Roseshter, Anna Klemantovich, Luca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, Oluwadara O. Elebute, Sarah Jenna, Jean-Francois Boileau, Manuela Pelmus, Mark Basik, Cathy Lan
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P2-11-26.
https://doi.org/10.1158/1538-7445.SABCS22-P2-11-26
Published: 01 March 2023
View article titled, Abstract P2-11-26: The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor
Journal Articles

Abstract HER2-15: HER2-15 Retrospective Study to Estimate the Prevalence and Describe the Clinicopathological Characteristics, Treatment Patterns, and Outcomes of HER2-Low Breast Cancer

Giuseppe Viale, Mark Basik, Naoki Niikura, Eriko Tokunaga, Sara Brucker, Frédérique Penault-Llorca, Naoki Hayashi, Joo Hyuk Sohn, Rita Teixeira de Sousa, Adam M. Brufsky, Ciara S. O’Brien, Fernando Schmitt, Gavin Higgins, Della Varghese, Gareth D. James, Akira Moh, Andrew Livingston, Victoria de Giorgio-Miller
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): HER2-15.
https://doi.org/10.1158/1538-7445.SABCS22-HER2-15
Published: 01 March 2023
View article titled, Abstract HER2-15: HER2-15 Retrospective Study to Estimate the Prevalence and Describe the Clinicopathological Characteristics, Treatment Patterns, and Outcomes of HER2-Low Breast Cancer
Journal Articles

Abstract P3-08-09: Development and molecular characterization of hard-to-treat breast cancer pre-clinical models to enhance precision medicine

Hellen Kuasne, Anne-Marie fortier, Sandrine Busque, Simon Mathien, Paul Savage, Constanza Martinez Ramirez, Anie Monast, Margarita Soleinova, Atilla Omeroglu, Jamil Asselah, Nathaniel Bouganim, Sarkis Meterissian, Mark Basik, Morag Park
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-08-09.
https://doi.org/10.1158/1538-7445.SABCS22-P3-08-09
Published: 01 March 2023
View article titled, Abstract P3-08-09: Development and molecular characterization of hard-to-treat breast cancer pre-clinical models to enhance precision medicine
Journal Articles

Abstract A033: Identification of gemcitabine-resistant populations using scRNA-sequencing in triple negative breast cancer patient-derived xenograft

Sandrine Busque, Constanza Martinez Ramirez, Hellen Kuasne, Paul Savage, Anne-Marie Fortier, Anie Monast, Atilla Omeroglu, Jamil Asselah, Nathaniel Bouganim, Sarkis Meterissian, Claudia Kleinman, Mark Basik, Morag Park
Journal: Cancer Research
Cancer Res (2023) 83 (2_Supplement_2): A033.
https://doi.org/10.1158/1538-7445.METASTASIS22-A033
Published: 15 January 2023
View article titled, Abstract A033: Identification of gemcitabine-resistant populations using scRNA-sequencing in triple negative breast cancer patient-derived xenograft
Journal Articles

Abstract 1794: The combination of Talazoparib with anti-her2 drugs shows efficacy in drug resistant Her2+ and low Her2 PDX models

Kathryn Bozek, Marguerite Buchanan, Cathy Lan, Josiane Lafleur, Cedric Darini, Urszula Krzemien, Adriana Aguilar-Mahecha, Mark Basik
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1794.
https://doi.org/10.1158/1538-7445.AM2022-1794
Published: 15 June 2022
View article titled, Abstract 1794: The combination of Talazoparib with anti-her2 drugs shows efficacy in drug resistant Her2+ and low Her2 PDX models
Journal Articles

Abstract 4011: Prognostic value of transcriptomic analysis in residual post neo-adjuvant triple negative breast cancer tumors

Adriana Aguilar-Mahecha, Yasamin Majedi, Oluwadara Elebute, Josiane Lafleur, Andreas Papadakis, Cathy Lan, Manuela Pelmus, Touhidur Rashid, Sarah Jenna, Mark Basik
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 4011.
https://doi.org/10.1158/1538-7445.AM2022-4011
Published: 15 June 2022
View article titled, Abstract 4011: Prognostic value of transcriptomic analysis in residual post neo-adjuvant triple negative breast cancer tumors
Journal Articles

Abstract 538: Cell-free whole genome sequencing for the detection of cancer in patients with germline BRCA1/2 mutations

Derek Wong, Adriana Aguilar-Mahecha, Josiane Lafleur, Clarissa Chan, Kirsten Farncombe, Maia Norman, Leslie Oldfield, Prabhjit Basra, Stephanie Pederson, Johanna Wellum, Stephenie Prokopec, Mark Basik, Raymond H. Kim, Trevor Pugh
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 538.
https://doi.org/10.1158/1538-7445.AM2022-538
Published: 15 June 2022
View article titled, Abstract 538: Cell-free whole genome sequencing for the detection of cancer in patients with germline <em>BRCA1/2</em> mutations
Journal Articles

Abstract PD7-07: Surgical management and contralateral breast cancer risk in women with a history of radiation therapy for Hodgkin lymphoma: Results from a population-based cohort

Elisheva R Eisenberg, Anna Weiss, Ipshita Prakash, Sonia Skamene, Mark Basik, Jean Francois Boileau, Lissa Ajjamada, Michael Pollak, Stephanie M Wong
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD7-07.
https://doi.org/10.1158/1538-7445.SABCS21-PD7-07
Published: 15 February 2022
View article titled, Abstract PD7-07: Surgical management and contralateral breast cancer risk in women with a history of radiation therapy for Hodgkin lymphoma: Results from a population-based cohort
Journal Articles

The MNK1/2–eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer

Qianyu Guo, Margarita Bartish, Christophe Gonçalves, Fan Huang, Julian Smith-Voudouris, Sai Sakktee Krisna, Samuel E.J. Preston, Audrey Emond, Vivian Z. Li, Claudia U. Duerr, Yirui Gui, Aurélie Cleret-Buhot, Pamela Thebault, Hanne Lefrère, Liesbeth Lenaerts, Dany Plourde, Jie Su, Barbara C. Mindt, Shannon A. Hewgill, Tiziana Cotechini, Charles C.T. Hindmarch, William Yang, Elie Khoury, Yao Zhan, Valeria Narykina, Yuhong Wei, Giuseppe Floris, Mark Basik, Frédéric Amant, Daniela F. Quail, Réjean Lapointe, Jörg H. Fritz, Sonia V. del Rincon, Wilson H. Miller, Jr
Journal: Cancer Research
Cancer Res (2021) 81 (14): 3876–3889.
https://doi.org/10.1158/0008-5472.CAN-20-3143
Published: 15 July 2021
View article titled, The MNK1/2–eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer
Open the PDF for The MNK1/2–eIF4E Axis Supports Immune Suppression and Metastasis in Postpartum Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PS4-48: Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer

Marta Zurawska, Adriana Aguilar-Mahecha, Mark Basik, Michal Dadlez, Dominik Domanski
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS4-48.
https://doi.org/10.1158/1538-7445.SABCS20-PS4-48
Published: 15 February 2021
View article titled, Abstract PS4-48: Development of a multiplexed protein panel using a targeted proteomics approach for the study of CDK4/6 inhibitors resistance in hormone receptor positive breast cancer
Journal Articles

Abstract 1968: Early on-treatment genomic instability level in cell free DNA as a predictive and prognostic marker in metastatic breast cancer patients

Adriana Aguilar-Mahecha, Josiane Lafleur, Susie Brousse, Cristiano Ferrario, Kimberly A. Holden, Graham McLennan, Taylor J. Jensen, Mark Basik
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1968.
https://doi.org/10.1158/1538-7445.AM2020-1968
Published: 15 August 2020
View article titled, Abstract 1968: Early on-treatment genomic instability level in cell free DNA as a predictive and prognostic marker in metastatic breast cancer patients
Journal Articles

Abstract 4108: The use of conditionally reprogrammed cells for high throughput screening for novel drug combinations to treat drug resistant triple negative breast cancers

Adriana Aguilar-Mahecha, Catherine Chabot, Nancy Santos-Martinez, Cedric Darini, Midhet Hajira, Tim Kong, Genevieve Morin, Sidong Huang, Morag Park, Mark Basik
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4108.
https://doi.org/10.1158/1538-7445.AM2020-4108
Published: 15 August 2020
View article titled, Abstract 4108: The use of conditionally reprogrammed cells for high throughput screening for novel drug combinations to treat drug resistant triple negative breast cancers
Journal Articles

Abstract GS5-05: Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery

Mark Basik, Reena S Cecchini, Jennifer F De Los Santos, Heidi R Umphrey, Thomas B Julian, Eleftherios P Mamounas, Julia White, Peter C Lucas, Christa Balanoff, Antoinette R Tan, Joseph J. Weber, David A Edmonson, Ursa A. Brown-Glaberman, Emilia J. Diego, Mediget Teshome, Cindy B Matsen, Samantha A Seaward, Irene L. Wapnir, Jamie L Wagner, Judy A Tjoe, Alastair M Thompson, Norman Wolmark
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS5-05.
https://doi.org/10.1158/1538-7445.SABCS19-GS5-05
Published: 15 February 2020
View article titled, Abstract GS5-05: Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery
Journal Articles

MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ

Qianyu Guo, Vivian Z. Li, Jessica N. Nichol, Fan Huang, William Yang, Samuel E.J. Preston, Zahra Talat, Hanne Lefrère, Henry Yu, Guihua Zhang, Mark Basik, Christophe Gonçalves, Yao Zhan, Dany Plourde, Jie Su, Jose Torres, Maud Marques, Sara Al Habyan, Krikor Bijian, Frédéric Amant, Michael Witcher, Fariba Behbod, Luke McCaffrey, Moulay Alaoui-Jamali, Nadia V. Giannakopoulos, Muriel Brackstone, Lynne-Marie Postovit, Sonia V. del Rincón, Wilson H. Miller, Jr
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (7): 1646–1657.
https://doi.org/10.1158/0008-5472.CAN-18-1602
Published: 01 April 2019
View article titled, MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <em>In Situ</em>
Open the PDF for MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma <em>In Situ</em> in another window
Includes: Supplementary data
Journal Articles

Abstract LB-177: Quantification of cell signaling proteins by immuno-MALDI

Robert Popp, René P. Zahedi, André LeBlanc, Yassene Mohammed, Adriana Aguilar-Mahecha, Oliver Pötz, Mark Basik, Gerald Batist, Christoph H. Borchers
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): LB-177.
https://doi.org/10.1158/1538-7445.AM2018-LB-177
Published: 01 July 2018
View article titled, Abstract LB-177: Quantification of cell signaling proteins by immuno-MALDI